Skip to content

Characteristic study of abnormal innate fear behavior in patients with focal epilepsy

Characteristic study of abnormal innate fear behavior in patients with focal epilepsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096049
Enrollment
Unknown
Registered
2025-01-16
Start date
2021-09-05
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

epilepsy:NA

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. All subjects are willing to accept the clinical trial and sign a dated written informed consent; 2. Meet the criteria for diagnosis and classification of epilepsy - New classification of seizures and epilepsy by the International League against Epilepsy in 2017; 3. Patients with focal epilepsy who have implanted intracranial electrodes and are undergoing EEG monitoring due to clinical needs; 4. Age >=13 years old and <=60 years old; 5. Does not suffer from other neurological diseases or other systemic diseases; 6. No obvious cognitive impairment; 7. Can see or hear (can wear eyes and hearing AIDS), can cooperate with the inspector's instructions; 8. Physical activity can be carried out simple keyboard operation; 9. Did not participate in other clinical trials.

Exclusion criteria

Exclusion criteria: 1. Severe intracranial diseases, such as intracranial hemorrhage, hemorrhagic infarction and massive infarction; 2. Have a serious underlying medical condition, including uncontrolled high blood pressure, severe diabetes, severe heart disease, failure of major organ systems requiring anticoagulant therapy other than aspirin, active infection, immunocompromised state, or malignancy with a life expectancy of less than 5 years; 3. The aphasia is severe enough to limit communication between the investigator and the patient; 4. Active depression (BDI> 20) or other untreated or uncontrolled mental illness (active anxiety disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder, or personality disorder (e.g., multiple personality disorder, borderline personality disorder, etc.) or other neuropsychiatric condition recommended to be excluded after a psychiatrist's evaluation; 5. Patients who have attempted suicide within the past 6 months; 6. A history of drug abuse in the past 3 years; 7. Patients who are pregnant or nursing, and who intend to become pregnant during the clinical study.

Design outcomes

Primary

MeasureTime frame
EEG frequency, amplitude, energy;reaction time and reaction accuracy;

Countries

China

Contacts

Public ContactXiaodong Cai

Shenzhen Second People's Hospital

13632660199@139.com+86 755 83366388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026